- Home
- CVKD vs MITQ Comparison
CVKD vs MITQ Comparison
Compare CVKD & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- MITQ
- Stock Information
- Founded
- CVKD 2022
- MITQ 2003
- Country
- CVKD United States
- MITQ United States
- Employees
- CVKD N/A
- MITQ N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- MITQ Telecommunications Equipment
- Sector
- CVKD Health Care
- MITQ Telecommunications
- Exchange
- CVKD Nasdaq
- MITQ Nasdaq
- Market Cap
- CVKD 6.9M
- MITQ 6.3M
- IPO Year
- CVKD 2023
- MITQ 2021
- Fundamental
- Price
- CVKD $12.00
- MITQ $0.53
- Analyst Decision
- CVKD Strong Buy
- MITQ
- Analyst Count
- CVKD 2
- MITQ 0
- Target Price
- CVKD $52.50
- MITQ N/A
- AVG Volume (30 Days)
- CVKD 44.9K
- MITQ 61.1K
- Earning Date
- CVKD 11-08-2024
- MITQ 11-11-2024
- Dividend Yield
- CVKD N/A
- MITQ N/A
- EPS Growth
- CVKD N/A
- MITQ N/A
- EPS
- CVKD N/A
- MITQ N/A
- Revenue
- CVKD N/A
- MITQ $20,139,000.00
- Revenue This Year
- CVKD N/A
- MITQ N/A
- Revenue Next Year
- CVKD N/A
- MITQ N/A
- P/E Ratio
- CVKD N/A
- MITQ N/A
- Revenue Growth
- CVKD N/A
- MITQ N/A
- 52 Week Low
- CVKD $5.40
- MITQ $0.42
- 52 Week High
- CVKD $32.55
- MITQ $1.44
- Technical
- Relative Strength Index (RSI)
- CVKD 55.95
- MITQ 38.91
- Support Level
- CVKD $11.00
- MITQ $0.54
- Resistance Level
- CVKD $15.37
- MITQ $0.57
- Average True Range (ATR)
- CVKD 1.43
- MITQ 0.03
- MACD
- CVKD -0.16
- MITQ -0.00
- Stochastic Oscillator
- CVKD 37.26
- MITQ 12.93
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation, and digital technology, as well as software solutions for operations enhancement and theatre management.